In addition, various studies have demonstrated a correlation between calreticulin expression and overall patient survival, which clearly distinguishes calreticulin from other DAMPs suggesting potential use of calreticulin as a prognostic marker for success of the RT in various types of cancer (89–92). This evidence concerns the gene CALR and cancer.